Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors

Por Kreil, Thomas R.
Publicado no Emerg Infect Dis (2015)

Emerging trends in plasma‐free manufacturing of recombinant protein therapeutics expressed in mammalian cells

Por Grillberger, Leopold, Kreil, Thomas R., Nasr, Sonia, Reiter, Manfred
Publicado em 2009

Neutralizing Antibodies Protect against Lethal Flavivirus Challenge but Allow for the Development of Active Humoral Immunity to a Nonstructural Virus Protein

Por Kreil, Thomas R., Maier, Elisabeth, Fraiss, Sabine, Eibl, Martha M.
Publicado em 1998

Influence of Extraction Protocol on Physical Properties of Parvovirus B19 DNA

Por Matz, Bertfried, Kupfer, Bernd, Kreil, Thomas R., Eis-Hübinger, Anna Maria
Publicado em 2010

West Nile Virus Infection in Plasma of Blood and Plasma Donors, United States

Por Planitzer, Christina B., Modrof, Jens, Yu, Mei-ying W., Kreil, Thomas R.
Publicado em 2009

Tick-Borne Encephalitis Virus-Neutralizing Antibodies in Different Immunoglobulin Preparations

Por Rabel, Philip O., Planitzer, Christina B., Farcet, Maria R., Kreil, Thomas R.
Publicado em 2012

Selection of recombinant MVA by rescue of the essential D4R gene

Por Ricci, Patricia S, Schäfer, Birgit, Kreil, Thomas R, Falkner, Falko G, Holzer, Georg W
Publicado em 2011

Human IgG Subclasses: In Vitro Neutralization of and In Vivo Protection against West Nile Virus

Por Hofmeister, Yvonne, Planitzer, Christina B., Farcet, Maria R., Teschner, Wolfgang, Butterweck, H. Arno, Weber, Alfred, Holzer, Georg W., Kreil, Thomas R.
Publicado em 2011

H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model

Por Howard, M. Keith, Sabarth, Nicolas, Savidis-Dacho, Helga, Portsmouth, Daniel, Kistner, Otfried, Kreil, Thomas R., Ehrlich, Hartmut J., Barrett, P. Noel
Publicado em 2011

Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever

Por Schäfer, Birgit, Holzer, Georg W., Joachimsthaler, Alexandra, Coulibaly, Sogue, Schwendinger, Michael, Crowe, Brian A., Kreil, Thomas R., Barrett, P. Noel, Falkner, Falko G.
Publicado em 2011

MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses

Por Hessel, Annett, Savidis-Dacho, Helga, Coulibaly, Sogue, Portsmouth, Daniel, Kreil, Thomas R., Crowe, Brian A., Schwendinger, Michael G., Pilz, Andreas, Barrett, P. Noel, Falkner, Falko G., Schäfer, Birgit
Publicado em 2014

Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients

Por Fritz, Richard, Hetzelt, Nicole, Ilk, Reinhard, Hohenadl, Christine, van der Velden, Maikel V. W., Aichinger, Gerald, Portsmouth, Daniel, Kistner, Otfried, Howard, M. Keith, Barrett, P. Noel, Kreil, Thomas R.
Publicado no Open Forum Infect Dis (2014)

Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines

Por Beck, Yvonne, Fritz, Richard, Orlinger, Klaus, Kiermayr, Stefan, Ilk, Reinhard, Portsmouth, Daniel, Pöllabauer, Eva-Maria, Löw-Baselli, Alexandra, Hessel, Annett, Kölch, Doris, Howard, M. Keith, Barrett, P. Noel, Kreil, Thomas R.
Publicado no J Virol (2016)

Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus ch...

Por Hohenadl, Christine, Wodal, Walter, Kerschbaum, Astrid, Fritz, Richard, Howard, M Keith, Farcet, Maria R, Portsmouth, Daniel, McVey, John K, Baker, Donald A, Ehrlich, Hartmut J, Barrett, P Noel, Kreil, Thomas R
Publicado em 2014

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity

Por Hessel, Annett, Schwendinger, Michael, Holzer, Georg W., Orlinger, Klaus K., Coulibaly, Sogue, Savidis-Dacho, Helga, Zips, Marie-Luise, Crowe, Brian A., Kreil, Thomas R., Ehrlich, Hartmut J., Barrett, P. Noel, Falkner, Falko G.
Publicado em 2011

A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations

Por Hessel, Annett, Schwendinger, Michael, Fritz, Daniela, Coulibaly, Sogue, Holzer, Georg W., Sabarth, Nicolas, Kistner, Otfried, Wodal, Walter, Kerschbaum, Astrid, Savidis-Dacho, Helga, Crowe, Brian A., Kreil, Thomas R., Barrett, P. Noel, Falkner, Falko G.
Publicado em 2010

A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly Immunogenic and Protective in Active Immunization and Passive Protection Mouse Models

Por Kistner, Otfried, Crowe, Brian A., Wodal, Walter, Kerschbaum, Astrid, Savidis-Dacho, Helga, Sabarth, Nicolas, Falkner, Falko G., Mayerhofer, Ines, Mundt, Wolfgang, Reiter, Manfred, Grillberger, Leopold, Tauer, Christa, Graninger, Michael, Sachslehner, Alois, Schwendinger, Michael, Brühl, Peter, Kreil, Thomas R., Ehrlich, Hartmut J., Barrett, P. Noel
Publicado em 2010